Johnson and Johnson made $3.8 Billion Just From Vaccines in 2019
Johnson & Johnson is a global medical device and pharmaceutical manufacturer based in New Brunswick NJ. They have over 130 years of experience providing medical solutions and have partnered with contract manufacturers to start phase 1 COVID-19 vaccine trials in September 2020. They aim to produce 600-900 million doses by April 2021, if phase 1 trials go as planned.
They Could Make Billions From a Covid 19 Vaccine
J&J said it is using the same technologies it used to make its experimental Ebola vaccine, which was provided to people in the Democratic Republic of Congo in late 2019. It involves combing genetic material from the coronavirus with a modified adenovirus that is known to cause common colds in humans. The company has previously said it could produce 600 million to 900 million doses by April if the vaccine works well....
- John Smith
Which Utah Politicians Work For Johnson and Johnson?
The Above Politicians Have Lost the Public's Trust
To "Sell" the Pandemic AND profit from it is an action worthy of the lowest contempt. Hopefully, this article will help the people of Utah recognize those working for the Public Interest, and those working for Personal and Political Gain at the expense of the Public. We will continue this series on Utah and Vaccines in future articles.